Trial · NCT07913191
Effect of Nurse-Directed Therapeutic Positioning in Children With Pneumonia
NCT07913191, Not applicable, Not yet recruiting, University of Baghdad
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Effect of Nurse-Directed Therapeutic Positioning in Children With Pneumonia. Trials, record NCT07913191. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07913191
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Nurse-Directed Therapeutic Positioning in Children With Pneumonia
- NCT number
- NCT07913191
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 150 participants, estimated
- Lead sponsor
- University of Baghdad
- Conditions
- Pediatric Pneumonia
- Interventions
- Nurse - Directed Side - Lying Positioning, Nurse - Directed Semi-fowler's positioning
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Respiratory Rate | At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention. | Respiratory rate will be measured in breaths per minute and compared among the semi-Fowler, side-lying, and control groups. |
| Primary | Change in Respiratory Distress Severity | At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention. | Respiratory distress severity will be assessed using the Clinical Respiratory Score (CRS), which consists of six parameters: respiratory rate, auscultation, use of accessory muscles, mental status, room air oxygen saturation, and skin color. Each parameter is scored from 0 to 2, yielding a total score ranging from 0 to 12. Higher scores indicate greater respiratory distress. Change in respiratory distress severity will be compared among the semi-Fowler, side-lying, and control groups. |
| Primary | Change in Peripheral Oxygen Saturation (SpO₂) | At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention. | Peripheral oxygen saturation will be measured using a pulse oximeter and compared among the semi-Fowler, side-lying, and control groups. |
| Primary | Change in Heart Rate | At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention. | Heart rate will be measured in beats per minute and compared among the semi-Fowler, side-lying, and control groups. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07913191
GET https://conductscience.org/api/trials/v1/NCT07913191/registered